1.800.KIDS DOC | 1.800.543.7362

Alexis A. Thompson, MD, MPH

Alexis A. Thompson, MD, MPH

Hematology Section Head; A. Watson and Sarah Armour Chair of Childhood Cancer and Blood Diseases

Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Hox A11 gene, plalelet disorders, bone marrow failure, thalassemia, hemophilia, sickle cell disease

Specialties, Programs & Conditions

Specialties:

Hematology & Oncology

Education & Training

Education: University of California (Health Services), LA, 1987 (MPH); Tulane University School of Medicine, 1983 (MD),

Postgraduate Training: Children's Hospital of Philadelphia, 1990; Children's Hospital of Los Angeles, 1986

Board Certifications: Pediatric Hematology-Oncology, General Pediatrics

Research

Research Interests: Sickle cell disease; thalassemia; blood transfusion; iron overload

Publications

Most recent publications

Feasibility and safety of home exercise training in children with sickle cell anemia Allergy64 (12):
Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease Br J Haematol175 (4): 705-713
Toward understanding family-related characteristics of young adults with sickle-cell disease or sickle-cell trait in the USA J Clin Nurs25 (11-12): 1587-97
Spirituality and Religiosity in Adolescents Living With Sickle Cell Disease West J Nurs Res38 (6): 686-703
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia Br J Haematol169 (6): 887-98
Reduced fitness and abnormal cardiopulmonary responses to maximal exercise testing in children and young adults with sickle cell anemia Physiol Rep3 (4):
Heart rate recovery is impaired after maximal exercise testing in children with sickle cell anemia J Pediatr166 (2): 389-393.e1
Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD) Blood124 (18): 2867-71
Relationship among chelator adherence, change in chelators, and quality of life in Thalassemia Qual Life Res23 (8): 2277-88
Effects of hydroxyurea treatment for patients with hemoglobin SC disease Am J Hematol91 (2): 238-42

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

News

3 Results

Fertility Preservation Gives Sisters Hope for Future

Gene Therapy for Blood Disorder Ends Need for Transfusions

Solving Luke's Mystery Illness

See all News & Stories >